Vitamins and Dietary Supplements Market Analysis in the Philippines

  • May 2014
  • -
  • Euromonitor International
  • -
  • 37 pages

A growing number of Filipinos put greater importance on preventive medicine in 2011, due to the lack of an efficient public healthcare system that provides hospitalisation subsidies, as well as the influence of the growing health and wellness trend. Vitamins and dietary supplements also benefited from increased consumption of these products amongst middle-income consumers, which drove performance in 2011.

Euromonitor International's Vitamins and Dietary Supplements in Philippines report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2007 to 2011, allowing you to identify the segments driving growth. Projections to 2016 illustrate how the industry is set to change.

Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.

Data coverage: indsutry size (historic and projections ), market shares, brand shares and distribution channel figures .

Reasons to Buy This Report

* Gain in-depth understanding of the Vitamins and Dietary Supplements industry ;

* Identify areas of growth and understand key dynamics ;

* Get a full overview of the competitive landscape, the industry ’s major players and leading brands;

* Anticipate market change with 5 year forecasts .

Table Of Contents

VITAMINS AND DIETARY SUPPLEMENTS IN THE PHILIPPINES

June 2012


LIST OF CONTENTS AND TABLES

Headlines
Trends
Vitamins
Dietary Supplements
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2011
Data table 1 Sales of Vitamins and Dietary Supplements by Segment : Value from 2006 to 2011
Data table 2 Sales of Vitamins and Dietary Supplements by Segment : % Value Growth from 2006 to 2011
Data table 3 Dietary Supplements by Positioning from 2006 to 2011
Data table 4 Vitamins and Dietary Supplements Market Shares by Value from 2007 to 2011
Data table 5 Vitamins and Dietary Supplements Brand Shares by Value from 2008 to 2011
Data table 6 Vitamins Brand Shares by Value from 2008 to 2011
Data table 7 Dietary Supplements Brand Shares by Value from 2008 to 2011
Data table 8 Projection Sales of Vitamins and Dietary Supplements by Segment : Value from 2011 to 2016
Data table 9 Projection Sales of Vitamins and Dietary Supplements by Segment : % Value Growth from 2011 to 2016
International Pharmaceuticals Inc in Consumer Health (philippines)
Strategic Direction
Key Facts
Summary 2 International Pharmaceuticals Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 International Pharmaceuticals Inc: Competitive Position 2011
Macropharma Corp in Consumer Health (philippines)
Strategic Direction
Key Facts
Summary 4 Macropharma Corp: Key Facts
Company Background
Production
Competitive Positioning
Summary 5 Macropharma Corp: Competitive Position 2011
Pascual Laboratories Inc in Consumer Health (philippines)
Strategic Direction
Key Facts
Summary 6 Pascual Laboratories Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Pascual Laboratories Inc: Competitive Position 2011
Philusa Corp in Consumer Health (philippines)
Strategic Direction
Key Facts
Summary 8 Philusa Corp: Key Facts
Summary 9 Philusa Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Philusa Corp: Competitive Position 2011
United Laboratories Inc in Consumer Health (philippines)
Strategic Direction
Key Facts
Summary 11 United Laboratories Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 12 United Laboratories Inc: Competitive Position 2011
Executive Summary
Consumer Health Records Stable Growth in 2011
More Filipinos Opt To Invest in Preventive Health Care
Domestic Player United Laboratories Maintains Leadership in 2011
Parapharmacies/drugstores Remains the Leading Distribution Channel
Stronger Growth Is Expected Over the Projection Period
Key Trends and Developments
Increasing Demand for Plant-based Treatments
Line Extensions Become Increasingly Popular
Growing Competition Between Consumer Health and Beauty and Personal Care
Celebrity Endorsement Remains A Popular Industry ing Tool
More Filipinos Opt To Invest in Preventive Health Care
Market Indicators
Data table 10 Consumer Expenditure on Health Goods and Medical Services from 2006 to 2011
Data table 11 Life Expectancy at Birth from 2006 to 2011
Market Data
Data table 12 Sales of Consumer Health by Segment : Value from 2006 to 2011
Data table 13 Sales of Consumer Health by Segment : % Value Growth from 2006 to 2011
Data table 14 Consumer Health Market Shares from 2007 to 2011
Data table 15 Consumer Health Brand Shares from 2008 to 2011
Data table 16 Sales of Consumer Health by Distribution Format: % Analysis from 2006 to 2011
Data table 17 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2011
Data table 18 Projection Sales of Consumer Health by Segment : Value from 2011 to 2016
Data table 19 Projection Sales of Consumer Health by Segment : % Value Growth from 2011 to 2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 13 Research Sources












View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Calcium Sensing Receptor (CaR or CaSR) Antagonists -Pipeline Insights, 2014

Calcium Sensing Receptor (CaR or CaSR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Calcium Sensing Receptor (CaR or CaSR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

Cytochrome P450, Family 24 (CYP24 or Vitamin D(3) 24-hydroxylase) Inhibitors -Pipeline Insights, 2014

Cytochrome P450, Family 24 (CYP24 or Vitamin D(3) 24-hydroxylase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cytochrome P450, Family 24 (CYP24 or Vitamin D(3) 24-hydroxylase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

Folic Acid Antagonists -Pipeline Insights, 2014

Folic Acid Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Folic Acid Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.